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Introduction
HIV-1 cure remains elusive despite HAART due to the
reservoirs of proviral DNA integrated into the human gen-
ome. Efforts to cure HIV-1 therefore need to aim at elimi-
nating proviral DNA from cellular reservoirs. The first
epigenetic signal identified in virus infected and uninfected
cells has been promoter methylation. Compelling evidence
confirms that specific promoter methylation can lead to
gene silencing. Previous studies have examined HIV-1-
epigenetics mostly in vitro.
Materials and methods
We determined methylation patterns in HIV-1 proviral
genomes from PBMCs obtained from 21 individuals with
a spectrum of disease progression. The CpGs in the long
terminal repeats (LTRs) of proviral DNA were investigated
by bisulfite sequencing in up to 85 genomic variants per
individual. This approach facilitates the study of the full
range of CpG methylation and sequence variability of
HIV-1 proviruses under conditions of natural selection in
human populations.
Results
In patients with advanced disease, the HIV-1 proviruses
remained essentially unmethylated in their LTRs. In one
long-term nonprogresssor, the percentage of methylated
proviruses varied from 0-77% at different times after
infection. More important and unexpected was the detec-
tion of three specific LTR-located CpG dinucleotides that
had been selectively mutated to TpAs in >20 out of the
32 samples analyzed. Comparison to 11 HIV-1 LTR
sequences in the Los Alamos HIV data base demon-
strated that mutations in the sites identified by our study
occurred more frequently than at other locations,
although the mutations were different from TpAs.
Conclusions
These specific CpGs, possibly including their abutting
sequences, might indicate weak spots in the proviral gen-
omes whose sacrifice by mutation to TpAs could enhance
the HIV-1 potential for long-term proviral survival. These
data suggest that the sites of the mutated CpGs occurring
at conserved sites may serve as potential targets for thera-
peutic interventions to eliminate integrated proviruses.
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